Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -2.81%58.9M | -20.22%118.74M | -21.76%60.6M | -13.16%148.84M | -13.54%77.45M | -20.48%35M | 6.43%171.4M | 15.03%131.42M | 20.91%89.58M | 35.17%44.01M |
| Operating income | -2.81%58.9M | -20.22%118.74M | -21.76%60.6M | -13.16%148.84M | -13.54%77.45M | -20.48%35M | 6.43%171.4M | 15.03%131.42M | 20.91%89.58M | 35.17%44.01M |
| Cost of sales | -1.18%-23.63M | 17.71%-45.72M | 16.96%-23.36M | 9.11%-55.56M | 12.14%-28.13M | 18.44%-12.96M | -7.67%-61.13M | -18.15%-47.66M | -23.68%-32.02M | -39.42%-15.89M |
| Operating expenses | -1.18%-23.63M | 17.71%-45.72M | 16.96%-23.36M | 9.11%-55.56M | 12.14%-28.13M | 18.44%-12.96M | -7.67%-61.13M | -18.15%-47.66M | -23.68%-32.02M | -39.42%-15.89M |
| Gross profit | -5.31%35.26M | -21.72%73.02M | -24.49%37.24M | -15.41%93.28M | -14.32%49.32M | -21.63%22.04M | 5.75%110.27M | 13.33%83.77M | 19.42%57.57M | 32.89%28.13M |
| Selling expenses | 1.34%-15.55M | 15.86%-31.81M | 15.89%-15.76M | 2.89%-37.8M | -0.83%-18.74M | 0.24%-9.07M | -1.94%-38.92M | -4.81%-27.73M | -8.45%-18.59M | -11.85%-9.09M |
| Administrative expenses | -1.95%-17.12M | 10.23%-36.15M | 6.32%-16.79M | 6.52%-40.26M | 6.99%-17.92M | -9.63%-8.81M | -4.98%-43.07M | -4.23%-28.01M | -1.73%-19.27M | -2.76%-8.04M |
| Special items of operating profit | -40.90%1.19M | -51.03%1.59M | 357.86%2.01M | 227.35%3.26M | 108.01%439K | 103.94%160K | -806.08%-2.56M | -399.86%-3.48M | -698.98%-5.48M | -406.98%-4.07M |
| Operating profit | -43.55%3.78M | -63.92%6.66M | -48.85%6.7M | -28.20%18.47M | -7.95%13.1M | -37.65%4.32M | 2.75%25.72M | 23.45%24.55M | 24.37%14.23M | 57.05%6.93M |
| Financing cost | 11.72%-211K | 29.70%-452K | 27.79%-239K | 3.60%-643K | 2.07%-331K | 7.57%-171K | 11.66%-667K | 9.56%-511K | 5.06%-338K | -6.94%-185K |
| Earning before tax | -44.73%3.57M | -65.16%6.21M | -49.40%6.46M | -28.85%17.82M | -8.10%12.77M | -38.48%4.15M | 3.20%25.05M | 24.42%24.04M | 25.32%13.89M | 59.09%6.75M |
| Tax | 52.65%-348K | 60.97%-1.13M | 65.89%-735K | 32.65%-2.9M | 33.96%-2.16M | 58.93%-651K | -3.81%-4.31M | -40.86%-4.73M | -59.25%-3.26M | -96.41%-1.59M |
| After-tax profit from continuing operations | -43.71%3.22M | -65.97%5.08M | -46.05%5.73M | -28.06%14.92M | -0.16%10.61M | -32.20%3.5M | 3.07%20.74M | 20.95%19.3M | 17.63%10.63M | 50.32%5.16M |
| Earning after tax | -43.71%3.22M | -65.97%5.08M | -46.05%5.73M | -28.06%14.92M | -0.16%10.61M | -32.20%3.5M | 3.07%20.74M | 20.95%19.3M | 17.63%10.63M | 50.32%5.16M |
| Profit attributable to shareholders | -43.71%3.22M | -65.97%5.08M | -46.05%5.73M | -28.06%14.92M | -0.16%10.61M | -32.20%3.5M | 3.07%20.74M | 20.95%19.3M | 17.63%10.63M | 50.32%5.16M |
| Basic earnings per share | -43.14%0.0029 | -66.17%0.0045 | -46.32%0.0051 | -28.11%0.0133 | 0.00%0.0095 | -32.61%0.0031 | 2.78%0.0185 | 21.13%0.0172 | 17.28%0.0095 | 48.39%0.0046 |
| Diluted earnings per share | -43.14%0.0029 | -66.17%0.0045 | 0.0051 | -28.11%0.0133 | 2.78%0.0185 | |||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.